top of page
Nuffield Health Warwickshire Hospital
The Chase, Old Milverton Lane,
Leamington Spa, CV32 6RW
Dr Edward Nash
Tel: 07811 490706
Email: regencyradiologyrespiratory
@gmail.com

Research Publications
Search
Nebulised and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 1.
Nash E, Stephenson A, Ratjen F, Tullis E. Art. No.: CD007168. DOI: 10.1002/14651858.CD007168.pub2
‘Cepacia syndrome’ associated with Burkholderia cepacia (genomovar I) infection in an adolescent with cystic fibrosis.
Nash EF, Thomas A, Whitmill R et al. Pediatr Pulmonol. 2010 Dec 30. [Epub ahead of print]
Prevelance of dyslipidemia in adults with cystic fibrosis.
Rhodes B, Nash EF, Tullis E et al. Cyst Fibros. 2010 Jan;9(1):24-8.
Survival of Burkholderia cenocepacia sepsis following lung transplantation in recipients with cystic fibrosis.
Nash EF, Coonar A, Kremer R et al. Transpl Infect Dis 2010; 12(6):551-554.
Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis.
Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, Honeybourne D. Thorax. 2011 Mar;66(3):259.
Impact of lung transplantation on serum lipids in adults with cystic fibrosis.
Nash EF, Stephenson A, Helm EJ et al. J Heart Lung Transplant. 2011 Feb; 30(2):188-93.
Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
Nash EF, Volling C, Gutierrez CA et al. Clin Transplant 2012; 26(1):34-41.
Intussusception in adults with cystic fibrosis: a case series with review of the literature.
Nash EF, Stephenson A, Helm EJ et al. Dig Dis Sci 2011; 56(12):3695-700.
Long-Term Impact of Liver Transplantation on Respiratory Function and Nutritional Status in Children and Adults with Cystic Fibrosis.
Dowman JK, Watson D, Loganathan S, Gunson BK, Hodson J, Mirza DF, Clarke J, Lloyd C, Honeybourne D, Whitehouse JL, Nash EF, Kelly D, van Mourik I, Newsome PN. Am J Transplant. 2012; 12(4):954-64.
Implications of the current UK welfare reforms for adults with cystic fibrosis.
Nash EF, Kavanagh D, Williams S, Bikmalla S, Gray A, Whitehouse JL. Clin Med 2011; 11(6):634.
Microbial contamination of non-invasive ventilation (NIV) devices used by adults with cystic fibrosis.
Mutagi A, Nash EF, Cameron S et al. J Hosp Infect. 2012; 81(2):104-8.
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A. Cochrane Database Syst Rev 2013 12;7:CD007168.
Abdominal pain in adults with cystic fibrosis.
Nash EF, Ohri CM, Stephenson AL, Durie PR. Eur J Gastroenterol Hepatol. 2014 Feb;26(2):129-3
Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals.
Hill M, Suri R, Nash EF, Morris S, Chitty LS. J Clin Med. 2014 Feb 14;3(1):176-90.
Employment in adults with cystic fibrosis.
Targett K, Bourke S, Nash E, Murphy E, Ayres J, Devereux G. Occup Med (Lond). 2014 Mar;64(2):87-94.
Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community.
Khiroya H, Pound R, Qureshi U, Brown C, Barrett J, Rashid R, Whitehouse JL, Turner AM, Nash EF. Open Respir Med J. 2015; 9:15-21.
TRAFFIC Study Group; TRANSPORT Study Group. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW et al. N Engl J Med 2015; 373(3):220-31.
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.
Barr HL, Halliday N, Cámara M, Barrett DA, Williams W, Forrester DL, Simms R, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Fogarty AW. Eur Respir J 2015; 46(4):1046-54.
Chest wall motion analysis in healthy volunteers and adults with cystic fibrosis using a novel Kinect-based motion tracking system.
Harte JM, Golby CK, Acosta J, Nash EF, Kiraci E, Williams MA, Arvanitis TN, Naidu B. Med Biol Eng Comput. 2016; 54(11):1631-1640.
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.
Bryant JM, Grogono DM, Rodriguez-Rincon D et al. Science 2016; 354(6313):751-757.
bottom of page